GeneDx Holdings Shares Decline Following Weak Q4 Revenue Guidance
GeneDx Holdings (WGS) shares experienced a decline in premarket trading following the release of its third-quarter results. While the company reported Q3 revenue that exceeded analyst consensus estimates, investor sentiment was dampened by the forward-looking guidance. The primary driver for the stock's downward movement was the company's revenue outlook for the fourth quarter, which fell short of Wall Street expectations. Despite the strong performance in the third quarter, the cautious projections for the upcoming period have led to immediate market pressure.
Tickers: $WGS
Topics: earnings report revenue guidance stock price movement